https://finance.yahoo.com/news/crispr-therapeutics-announces-preclinical-data-100100038.html
0
0
40 words
0
Comments
-CTX310™ led to durable reductions of angiopoietin-like 3 protein (ANGPTL3) and triglyceride levels in non-human primates (NHPs) after a single dose- -CTX320...
You are the first to view
Create an account or login to join the discussion